Validation of the REMA Score for Predicting Systemic Mastocytosis in Patients with Mast Cell Activation Disorders

被引：0
|
作者：
Alvarez-Twose, I. [1 ]
Gonzalez-de-Olano, D. [2 ]
Sanchez-Munoz, L. [1 ]
Matito, A. [1 ]
Morgado, J. [1 ]
Jara-Acevedo, M. [3 ]
Teodosio, C. [3 ]
Garcia-Montero, A. [3 ]
Orfao, A. [3 ]
Escribano, L. [1 ]
机构：
[1] Inst Estudios Mastocitosis Castilla La Mancha, Toledo, Spain
[2] Hosp Fuenlabrada, Madrid, Spain
[3] Univ Salamanca, Ctr Invest Canc, IBMCC, Serv Gen Citometr, E-37008 Salamanca, Spain
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 127卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2010.12.988
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB248 / AB248
页数：1
相关论文
共 50 条
  • [41] Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia
    Giannetti, Matthew P.
    Godwin, Grace
    Weller, Emily
    Butterfield, Joseph H.
    Castells, Mariana
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (05) : 1225 - 1227
  • [42] Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria
    Valent, P
    Akin, C
    Sperr, WR
    Escribano, L
    Arock, M
    Horny, HP
    Bennett, JM
    Metcalfe, DD
    LEUKEMIA RESEARCH, 2003, 27 (07) : 635 - 641
  • [43] mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
    Rama, Tiago Azenha
    Moreira, Andre
    Castells, Mariana
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (03) : 877 - 878
  • [44] A Phase 2/3 Study of BLU-263 in Patients with Indolent Systemic Mastocytosis or Monoclonal Mast Cell Activation Syndrome
    Castells, Mariana
    Si, Tuan Dong
    Bhavsar, Vishwa
    He, Kevin
    Akin, Cem
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB221 - AB221
  • [45] Altered mast cell reactivity in patients with mastocytosis
    Gulen, T.
    Lyberg, K.
    Westerberg, Moeller C.
    Ekoff, M.
    Alexeyenko, A.
    Dahlen, B.
    Nilsson, G.
    ALLERGY, 2017, 72 : 445 - 445
  • [46] Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms
    Alvarez-Twose, Ivan
    Gonzalez de Olano, David
    Sanchez-Munoz, Laura
    Matito, Almudena
    Esteban-Lopez, Maria I.
    Vega, Arantza
    Belen Mateo, Maria
    Alonso Diaz de Durana, Maria D.
    de la Hoz, Belen
    del Pozo Gil, Maria D.
    Caballero, Teresa
    Rosado, Ana
    Sanchez Matas, Isabel
    Teodosio, Cristina
    Jara-Acevedo, Maria
    Mollejo, Manuela
    Garcia-Montero, Andres
    Orfao, Alberto
    Escribano, Luis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (06) : 1269 - 1278
  • [47] New Insights into Clonal Mast Cell Disorders Including Mastocytosis
    Volertas, Sofija
    Schuler, Charles F.
    Akin, Cem
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2018, 38 (03) : 341 - +
  • [48] Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis
    Boehm, Thomas
    Ristl, Robin
    Joseph, Saijo
    Petroczi, Karin
    Klavins, Kristaps
    Valent, Peter
    Jilma, Bernd
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (06) : 1533 - 1544
  • [49] Anaesthesia for patients with systemic mastocytosis: what mast we do?
    Gabrhelova, L.
    Khan, I.
    Hegde, P.
    ANAESTHESIA, 2018, 73 : 81 - 81
  • [50] Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
    Siegert, SI
    Diebold, J
    Ludolph-Hauser, D
    Löhrs, U
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (04) : 560 - 565
12345